Pentwater Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.91M | Buy |
300,000
+80,000
| +36% | +$2.64M | 0.06% | 44 |
|
|
2025
Q1 | $8.84M | Sell |
220,000
-870,000
| -80% | -$35M | 0.07% | 44 |
|
|
2024
Q4 | $51.3M | Sell |
1,090,000
-10,000
| -0.9% | -$470K | 0.57% | 19 |
|
|
2024
Q3 | $58.1M | Sell |
1,100,000
-19,000
| -2% | -$1M | 0.6% | 20 |
|
|
2024
Q2 | $60.6M | Buy |
1,119,000
+39,000
| +4% | +$2.11M | 0.78% | 19 |
|
|
2024
Q1 | $75.7M | Buy |
+1,080,000
| New | +$75.7M | 0.78% | 14 |
|